Skip to Main Content (Press Enter)

Logo UNINSUBRIA
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze

UNI-FIND
Logo UNINSUBRIA

|

UNI-FIND

uninsubria.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze
  1. Pubblicazioni

CLINICAL CANCER RESEARCH

Rivista
Codice:
E038182
ISSN:
1078-0432
  • Dati Generali

Dati Generali

Pubblicazioni (28)

  • ascendente
  • decrescente
A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast
Articolo
Allelotypes and fluorescence in situ hybridization profiles of poorly differentiated endocrine carcinomas of different sites
Articolo
Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non-small cell lung cancer
Articolo
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory
Articolo
Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms
Articolo
Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy
Articolo
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
Articolo
Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma
Articolo
Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial
Articolo
Different molecular profiles characterize well-differentiated endocrine tumors and poorly differentiated endocrine carcinomas of the gastroenteropancreatic tract
Articolo
Farnesyltransferase inhibitors and human malignant pleural mesothelioma: a first-step comparative translational study.
Articolo
IGF-IR INHIBITION MODULATES HIF-1 ALPHA EXPRESSION/ACTIVITY AND ENHANCES THE CYTOTOXICITY OF TEMOZOLOMIDE IN HUMAN GLIOBLASTOMA CELLS
Abstract
Inhibition of Kaposi's sarcoma in vivo by fenretinide
Articolo
Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up
Articolo
Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate
Articolo
Molecular pathways for cancer angioprevention
Articolo
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Articolo
Polyclonal immunoglobulin E levels are correlated with hemoglobin values and overall survival in patients with multiple myeloma
Articolo
REDUCED EXPRESSION OF INTERLEUKIN 6 (IL-6) IN UNDIFFERENTIATED THYROID CARCINOMA: IN VITRO AND IN VIVO STUDIES
Articolo
Reduced expression of interleukin 6 in undifferentiated thyroid carcinoma: in vitro and in vivo studies
Articolo
Risk of second cancer in nongastric marginal zone B-cell lymphomas of MALT: a population-based study from Northern Italy
Articolo
Sequential Immunogene Therapy with Interleukin-12- and Interleukin-15-Engineered Neuroblastoma Cells Cures Metastatic Disease in Syngeneic Mice.
Articolo
Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin
Articolo
The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
Articolo
The piperidine nitroxideTEMPOL modulates HIF-1 alpha in human glioblastoma cells
Articolo
The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide
Articolo
The transforming growth factor-β family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl) retinamide
Articolo
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
Articolo
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} di {itemsNumber}
  • Accessibilità
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.1.0